GGTLC1 and non-small cell lung carcinoma: In NSCLC, Single-cell RNA sequencing reveals T cell senescence correlates with poor prognosis, with a validated risk model (SLC2A1/TNS4/GGTLC1 signature, AUC > 0.8) predicting immunotherapy resistance.